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Nocardia neocaledoniensiswas introduced as a new environmental species ofNocardia in 2004. We present the first case of hu-
man skin and soft tissue infection caused by this species in a patient with rheumatoid arthritis receiving prednisone andmetho-
trexate therapy.
CASE REPORT
A68-year-old man with a history significant for rheumatoidarthritis receiving prednisone and methotrexate therapy for
at least 10 years presented for evaluation of a persistent right facial
abscess. The patient lived in a house in a residential area in Central
Texas, was a retired telephone employee, and volunteered as a
firefighter, with moderate exposure to dirt. His hobbies included
hunting, fishing, and mowing the lawn. He had no recent travel
outside his hometown, and no history of opportunistic infections.
Approximately 1month prior to presentation, he noticed right
facial discomfort and abscess formation in his right jaw. His pri-
mary care physician prescribed cephalexin, but the patient had
minimal relief of symptoms. The patient was referred to an oto-
laryngologist and a specimen was obtained by fine-needle aspira-
tion. TheGram stain of the specimen revealedmany polymorpho-
nuclear leukocytes, but no organisms were observed. The
corresponding culture recovered an organism suggestive of No-
cardia species. The patient was started on oral trimethoprim-sul-
famethoxazole therapy, and his methotrexate treatment was dis-
continued. The patient underwent incision and drainage 9 days
later due to increased drainage, and the resulting specimen once
again revealed a Nocardia species with susceptibilities similar to
those of the first isolate, as well as the presence of coagulase-neg-
ative staphylococci. The patient reported that he was compliant
with trimethoprim-sulfamethoxazole; however, 22 days after the
initial drainage, additional masses were noted in the same region.
A magnetic resonance image (MRI) of the brain was negative for
acute intracranial abnormalities.
On the basis of continued infection despite oral outpatient
antibiotic therapy, the patient was admitted to the hospital. On
admission, the patient denied cardiac, pulmonary, and gastroin-
testinal symptoms. On physical examination, his left submandib-
ular gland was normal but the right submandibular triangle had a
large mass (10.5 cm diameter) adjacent to the inferior border of
themandible. The areawas erythematous and tender to palpation.
Further examination of the right angle of the jaw submaxillary
triangle area revealed two additional masses, one anterior and one
posterior to the previous incision area. Both were firm and ex-
tremely tender to touch. Imaging of the neck and lungs did not
reveal any sinus tract or acute pulmonary abnormalities. The pa-
tient was placed on intravenous imipenem and oral trim-
ethoprim-sulfamethoxazole therapy. He underwent subsequent
incision and drainage of the multiple skin abscesses. The patient’s
hospital course was complicated by acute renal insufficiency and
hyponatremia, and his antibiotics were later switched to oral
doxycycline with the addition of oral moxifloxacin. The patient
remained clinically stable, with improvement in his signs and
symptoms.
Operative cultures were obtained from each abscess, and all
grewNocardiawith the samephenotypic characteristics (lysozyme
[], urease [], and negative hydrolysis of casein, tyrosine, and
xanthine, a pattern typical of several species within the former
Nocardia asteroides complex). In each instance, the organism was
recovered on sheep blood agar at 48 h after incubation at 35°C.
The colonies were chalky white with a pinkish tinge (Fig. 1), and
the organisms were modified acid-fast stain positive. Each culture
also exhibited the same susceptibility pattern (Table 1) when
Received 29 February 2012 Returned for modification 29 March 2012
Accepted 8 July 2012
Published ahead of print 11 July 2012
Address correspondence to Robert Fader, rfader@swmail.sw.org.
Copyright © 2012, American Society for Microbiology. All Rights Reserved.
doi:10.1128/JCM.00559-12
FIG 1 Colony morphology of N. neocaledoniensis. Note pinkish hue to the
colonies. Smooth colonies are coagulase-negative Staphylococcus.
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tested with a Sensititre rapid growingmycobacterial susceptibility
panel (TREK Diagnostic Systems, Cleveland, OH) by using Clin-
ical and Laboratory Standards Institute (CLSI) guidelines (3) and
incubated at 30°C for 3 days. Pathology was negative for malig-
nancy and fungal organisms.
Sequence-based identification was performed by sequencing
of the complete 16S rRNA gene and amino acid sequencing of the
secA1 gene (5, 6) according to standard methods (4). A sequence
comparison using the RipSeq Single (Isentio US LLC, Sunnyvale,
CA)G1bacterial database, which contains all published references
from valid species, indicated that the isolate was a member of an
unusual species of Nocardia (N. neocaledoniensis). The isolate
shared 1,390 and 1,397 bp of identity with no gaps (99.5% iden-
tity) with sequences of the DSM 4417T Nocardia neocaledoniensis
type strain (GenBank accession no. JF797311 and GQ85380) (2)
by complete 16S rRNA gene sequence analysis. An identity
of 99.5% with the 16S rRNA gene is considered adequate for a
species identification for Nocardia (4). By secA1 analysis, the iso-
late showed 99% amino acid identity (one amino acidmismatch),
which meets the species definition of the gene analysis (4). The
nearest other validated species type strain by complete 16S rRNA
gene sequencing and secA1 analysis was N. thailandica. The 16S
rRNAand secA1 gene sequences have been submitted toGenBank.
Nocardia species are Gram-positive, variably acid-fast, strictly
aerobic bacteria that formbranchedfilaments (7). Transmission is
mainly from inhalation or direct contact, and the bacteria have
been reported to cause cutaneous, subcutaneous, lymphocutane-
ous, central nervous system, pulmonary, and systemic infections
(1). Immunocompromise has been noted in numerous reports as
a risk factor for nocardiosis. These characteristics correlate with
the case of our patient, who was a recipient of both steroids and
methotrexate for at least 10 years to treat rheumatoid arthritis.
In 2004, Saintpierre-Bonaccio et al. (9) reported the pheno-
typic and genotypic characteristics that distinguished N. neocale-
doniensis from other strains of Nocardia. This organism was iso-
lated from soil in New Caledonia. N. neocaledoniensis has been
isolated from clinical specimens obtained from three patients with
conjunctivitis, although its role as a pathogen was questioned
(10). The organism has also been implicated inmastitis outbreaks
among Italian dairy herds (8). Our patient was found to have N.
neocaledoniensis skin and soft tissue infection, identified through
phenotypic and genotypic characteristics, which hemay have con-
tracted through occupational or recreational exposure. The initial
unsatisfactory response of this patient to oral trimethoprim-sul-
famethoxazole as an outpatient may have been secondary to the
abscess formation requiring surgical drainage. The susceptibility
of this isolate is documented in Table 1. He improved upon treat-
ment with oral trimethoprim-sulfamethoxazole plus intravenous
imipenem in conjunction with surgical debridement and later
with oral doxycycline andmoxifloxacin. To the best of our knowl-
edge, this is the first report of human skin and soft tissue infection
caused byN. neocaledoniensis and provides evidence of this species
as a human pathogen. It is likely that newer pathogenic species of
Nocardia will continue to emerge with the use of sequencing for
organism identification.
Nucleotide sequence accession number. Sequence data for
the isolate reported in this article have been submitted toGenBank
under accession numbers JX297205 (secA1) and JX297206 (16S
rRNA).
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TABLE 1 Susceptibility results of the clinical isolate of N.
neocaledoniensis by broth microdilution
Antibiotic(s) MIC(s) (g/ml) Interpretation
Amikacin 1 S
Amoxicillin/clavulanate 64/32 R
Cefepime 8 S
Ceftriaxone 4 S
Ciprofloxacin 2 I
Clarithromycin 2 S
Doxycycline 1 S
Imipenem 2 S
Linezolid 1 S
Moxifloxacin 0.5 S
Tobramycin 1 S
Trimethoprim-sulfamethoxazole 1/9 S
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